Quest Diagnostics (DGX) PT Lowered to $98 at Morgan Stanley
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $215.72 -0.14%
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
15 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
Morgan Stanley analyst Ricky Goldwasser lowered the price target on Quest Diagnostics (NYSE: DGX) to $98.00 (from $101.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Bajaj Housing Finance (BAJAJHFL:IN) to Neutral
- BYD Co Ltd (002594:CH) (BYDDY) PT Lowered to HK$107 at Macquarie
- Daikin Industries Ltd. (6367:JP) (DKILY) PT Raised to JPY25,000 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
